Chemoprevention of bladder cancer
โ Scribed by Dragan J. Golijanin; David Kakiashvili; Ralph R. Madeb; Edward M. Messing; Seth P. Lerner
- Publisher
- Springer-Verlag
- Year
- 2006
- Tongue
- English
- Weight
- 747 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0724-4983
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The chemopreventive efficacy of several compounds was evaluated in the N-butyl-N-(4-hydroxybuty1)nitrosamine (OH-BBN)-induced urinary bladder cancer model using C57BU6 x DBN2F1 (BDF) male mice. Compounds were administered in a defined semipurified diet (AIN-76-A) either as single agents or in combin
The term cancerchemoprevention refers to the prevention or prolongation of carcinogenesis by intervention with drugs prior to the malignant (i.e., invasive) stage. The development of chemopreventive drugs is the major objective of the Chemoprevention Branch of the National Cancer Institute. Neoplast
Encouraging results from several recent trials have increased interest in the potential of chemoprevention in reducing the incidence of cancer. Treatment with 1 3 4 sretinoic acid has reversed oral leukoplakia, a premalignant lesion, and prevented the development of second primary carcinomas of the
Lags behind prevention of other diseases